Company Filing History:
1 out of 5 
1 out of 440 
Years Active: 2011
Title: Hiroomi Kiyono: Innovator in Pharmaceutical Crystallization
Introduction
Hiroomi Kiyono is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of specific crystal forms of important compounds. His work has implications for drug formulation and stability.
Latest Patents
Kiyono holds a patent for a method for producing alpha form crystals of sapropterin hydrochloride. This innovative method involves dissolving sapropterin hydrochloride with hydrochloric acid at a concentration of not less than 4 mol/L at temperatures exceeding 70 degrees Celsius. The process continues by adding heated ethanol to the solution and cooling it at a controlled rate to precipitate stable alpha form crystals.
Career Highlights
Throughout his career, Kiyono has worked with prominent companies in the pharmaceutical industry. He has been associated with Shiratori Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited. His expertise in crystallization techniques has been instrumental in advancing pharmaceutical manufacturing processes.
Collaborations
Kiyono has collaborated with notable colleagues, including Katsumi Hotoda and Shinnosuke Tazawa. These partnerships have contributed to the development of innovative solutions in the pharmaceutical sector.
Conclusion
Hiroomi Kiyono's contributions to the field of pharmaceutical crystallization highlight his role as an innovator. His patented method for producing alpha form crystals of sapropterin hydrochloride showcases his expertise and commitment to advancing drug formulation techniques.